A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation

Sayaka MatsumotoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan, Correspondence[email protected]

Mitsuharu UedaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Taro YamashitaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Tomoko AmanoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Yohei MisumiDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Masayoshi TasakiDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan, ;Department of Morphological and Physiological Sciences, Graduate School of Health Sciences, Kumamoto University, Kumamoto, Japan, and

Teruaki MasudaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Mayumi MizukamiDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

Hirokazu FuruyaDepartment of Neurology, Kochi Medical School, Kochi University, Kochi, Japan

Yukio AndoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan,

show all

References

Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057–62.
PubMed Web of Science ®Google Scholar
Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411–23.
PubMed Web of Science ®Google Scholar
Terazaki H, Ando Y, Misumi S, Nakamura M, Ando E, Matsunaga N, Shoji S, et al. A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels. Biochem Biophys Res Commun 1999;264:365–70.
PubMed Web of Science ®Google Scholar
Lim A, Prokaeva T, Connor LH, Falk RH, Skinner M, Costello CE. Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid 2002;9:134–40.
PubMed Web of Science ®Google Scholar
Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid 2006;13:236–49.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date